INTERCEPT PHARMACEUTICALS INC 4
4 · INTERCEPT PHARMACEUTICALS INC · Filed Jul 5, 2017
Insider Transaction Report
Form 4
McMinn Rachel
Chief Strategy Officer
Transactions
- Sale
Common Stock
2017-07-03$121.78/sh−257$31,297→ 17,288 total
Footnotes (1)
- [F1]Each employee of the Issuer who has received restricted stock awards has agreed to a mandatory sale of a sufficient number of shares of common stock to cover his or her withholding tax amounts upon the vesting of such restricted stock awards. The sales denoted here were made pursuant to such agreement to cover withholding tax obligations of the employee.